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1. Introduction  
Diabetes mellitus is associated with complications from a variety of tissues in the human 
body. Among them, diabetic neuropathy is a devastating complication leading to severe 
disability and even mortality. Neuropathy is common among type 1 and 2 diabetic patients 
and may yet be detected at the time of diagnosis among type 2 diabetic patients. The 
symptoms the patients experience vary from sensory disturbances with pain to muscle 
wasting.  The results of autonomic neuropathy should also be considered as a severe 
problem in the patients, but will not be discussed in the present chapter.  
The possibilities to treat diabetic neuropathy are limited and a strict glycaemic control has 
mainly been advocated. The pathophysiology of diabetic neuropathy is complex and 
includes e.g. biochemical disturbances and vascular factors. Of the former, the polyol 
pathway has been the target for pharmacological attention. Based on the detailed 
knowledge of the polyol pathway, obtained from experimental models and human studies, 
that sorbitol accumulates in peripheral nerve trunks, pharmacological substances were 
developed with the purpose to decrease sorbitol levels. Such aldose reductase inhibitors 
have in different studies shown promising results (Bril et al., 2009; Hotta et al., 2008; Oates, 
2008; Schemmel et al., 2010), but are still at a stage of development. Presently, various 
strategies are emerging on the management of diabetic neuropathy, where it is stressed that 
an appropriate diagnosis is crucial and that the condition is not untreatable (Perkins & 
Krolewski, 2005). In the present chapter, we present a different approach than treatment 
with pharmacological substances or focusing on the glycaemic level; namely, utilization of 
the capacity of the brain to adapt to alterations. Thus, our intention is to use the plasticity of 
the brain as a treatment strategy – i.e. targeted plasticity. 
2. Peripheral neuropathy  
A peripheral neuropathy in diabetes may affect both the upper and lower extremities, where 
the latter location is more common and has gained more attention in research on diabetic 
neuropathy. Up to 50% of patients with diabetes in the United States may have a neuropathy 
in the lower extremity (Dyck et al., 1993). The prevalence of neuropathy in diabetes may vary 
from different studies depending on which diabetic population is examined, e.g. differences in 
Europe and Asia have been reported (Abbott et al., 2010; Rubino et al., 2007). In addition, 
various techniques, such as electrophysiology, examination of vibrotactile sense, skin and 
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nerve biopsies and monofilament tests, have been used to detect neuropathy in diabetes. 
However, although the intense research over the years on various aspects of diabetic 
neuropathy the mechanisms, which include biochemical and vascular components, behind the 
different types of neuropathies in diabetes are not clarified. The pathophysiology of the 
neuropathy is multifaceted and not completely elucidated, although peripheral nerve 
dysfunction and established neuropathy in diabetes seem to be related to the degree of 
hyperglycaemia (Lehtinen et al., 1989; Malik et al., 1993). Recently, some studies on diabetic 
neuropathy with long term data on HbA1c levels available have not found any association 
between glycaemic level and larger fibre neuropathy (vibrotactile sense) (Dahlin et al., 2011). A 
specific issue in this context is if even impaired glucose tolerance can induce neuropathy, but 
so far large myelinated nerve fibre neuropathy is probably not associated with impaired 
glucose tolerance (Dahlin et al., 2008). However, reports indicate that small nerve fibre 
dysfunction is present in patients with impaired glucose intolerance (Dahlin et al., 2008). The 
latter condition and the question of possible presence of neuropathy is a complex issue and are 
beyond the focus of the present chapter. 
2.1 Diabetic foot ulcers 
A particular problem in diabetes is the diabetic foot ulcer, which induces severe problems 
for the patients (Bengtsson et al., 2008) and causes tremendous costs for society (Prompers et 
al., 2008). It has long been known that diabetes may itself play an active part in the causation 
of perforating foot ulcers (Londahl et al., 2010). Foot ulcers are common in diabetic patients 
and associated with high morbidity and mortality. The prevalence of diabetic foot ulcer is 
1.7 – 2.9% and the annual population based incidence among diabetic patients is 1.9 – 3.6%. 
Interestingly, the annual incidence rates of foot ulcers in patients with diabetic neuropathy 
vary from 5 to 7% (Abbott et al., 2010) and the recurrence rate is high. It is estimated that 
70% of healed foot ulcers recur within five years (Apelqvist et al., 1993).  It is generally 
accepted that the majority of amputations in diabetes are preceded by foot ulcers on the 
same leg with a lifetime risk of a foot ulcer estimated to reach 15-25%, where the majority of 
the ulcers are located to the toes.  
The main cause of diabetic foot ulcers are neuropathy and macro- and microvascular 
disease, but also other factors may increase the risk for an ulceration (Londahl et al., 2010). 
Patients with loss of sensation in the foot seem to have a sevenfold increased risk of 
developing foot ulcers as compared to diabetic patients without neuropathy (Young & 
Harris, 1994). In addition, a defect proprioception due to neuropathy may also cause 
impaired balance and postural instability contributing to the risk for foot ulceration. In 
clinical practice, sensory neuropathy is usually evaluated using monofilaments, 128 Hz tune 
fork or biothesiometer, where the latter is considered to be the most appropriate method 
(Edmonds, 2004). However, a multifrequency technique to examine vibrotactile sense has 
not previously been used to evaluate neuropathy in the foot, particularly as related to the 
risk for recurrence of foot ulcers. It may be an exiting approach in the future to refine 
detection of neuropathy. Interestingly, adjunct hyperbaric oxygen therapy, used in a 
multidisciplinary setting, can improve healing of chronic diabetic foot ulcers (Londahl et al., 
2010); a therapy that may also beneficial in nerve regeneration after injury.  
2.2 Carpal tunnel syndrome in diabetes 
Diabetic patients have an increased prevalence of one of the most common peripheral nerve 
compression lesions, i.e. carpal tunnel syndrome (CTS), which is compression of the median 
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nerve at wrist level. It has a prevalence of 2-4% in the general population, while in diabetes 
it may be as high as 15%. Furthermore, if the subject has diabetic neuropathy in the lower 
extremity, the prevalence of CTS may approach 30% (Perkins et al., 2002). Interestingly, it 
has been shown that there seems to be an increased general susceptibility to peripheral 
nerve compression in diabetic rats (Dahlin et al., 2008), which can be related to disturbed 
axonal transport and a propensity to inhibit such transport in compression of diabetic 
nerves (Dahlin et al., 1987; Dahlin et al., 1986). 
Previously, it has been stated that surgical release of the median nerve in the carpal tunnel 
has no benefit for the patients and their symptoms from the CTS. Two previous studies 
showed diverse results (Mondelli et al., 2004; Ozkul et al., 2002), and proper conclusions can 
be difficult due to definition and selection of patients, extent of neuropathy and many other 
factors. Recently, we presented a prospective study where the outcome after surgical release 
of the carpal ligament was examined in diabetic patients with CTS and compared with age- 
and gender-matched healthy patients with CTS. The overall conclusion was that diabetic 
patients with CTS do benefit from surgical release of the carpal ligmament. This statement is 
relevant irrespective of the severity of the compression lesion or if signs of peripheral 
neuropathy are present (Thomsen et al., 2009). However, our data do not support a general 
view that any peripheral nerve trunk in diabetic patients should be surgically released. 
3. Introduction to brain plasticity 
The brain has been seen as a rather static organ until about 20 years ago. It was widely 
believed by neuroscientists that no new neural connections could be formed in the adult 
brain (Kandel et al., 2000; Purves, 2004). It was assumed that once connections had been 
established in foetal life, or in early infancy, they hardly changed later in life. This stability 
of connections in the adult brain has often been used to explain why there is usually very 
little functional recovery after damage to the nervous system. On the other hand, memory 
and learning require that some changes are possible also in the adult brain (Kandel et al., 
2000). It has often been assumed that these phenomena are based on small changes at the 
synaptic level and do not necessarily involve alterations in the basic circuit of the brain. 
The picture has changed radically in the last decades. One of the most interesting questions 
in neuroscience concerns the manner in which the nervous system can modify its 
organisation and ultimately its function throughout an individuals lifetime based on 
sensory input, experience, learning and injury (Donoghue, 1996; Kaas, 1991); a phenomenon 
that is often referred to as brain plasticity (Kandel et al., 2000; Purves, 2004). 
3.1 Plasticity in the adult somatosensory pathways 
There is a complete somatotopic map of the entire body surface in the somatosensory cortex 
of primates (Kaas et al., 1983; Merzenich et al., 1983). Merzenich et al (Merzenich et al., 1984) 
showed that after amputation of the middle finger of adult primates, the area in the cortex 
corresponding to the amputated digit began, within two months, to respond to touch 
stimuli presented to the adjacent digits; i.e. this area is “taken over” by sensory input from 
adjacent digits. Merzenich et al (Merzenich et al., 1984) also showed that if a monkey “used” 
one finger excessively, for an hour and a half a day, then, after 3 months, the area of cortex 
corresponding to that finger “expanded” at the expense of adjacent fingers. Furthermore, if 
a monkey was forced to always use two fingers jointly by suturing two of its fingers 
together, it was found at seven weeks that single neurons in area 3b in the primary 
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somatosensory cortex had receptive fields that spanned the border separating the two digits. 
Interestingly, if more than one finger was amputated there was no “take over” beyond 
about 1 mm of cortex. Merzenich et al (Merzenich et al., 1987) concluded from this that the 
expansion is probably mediated by arborisation of thalamo-cortical axons that typically do 
not extend beyond 1 mm. The figure 1 mm has often been cited as the fixed upper limit of 
reorganization of sensory pathways in adult animals (Calford, 1991). Pons et al (Pons et al., 
1991), however, suggested that this view might be incorrect. They found that after long-term 
(12 years) deafferentation of an upper limb, the cortical area originally corresponding to the 
hand in the primary somatosensory cortex was taken over by sensory input from the face. 
The cells in “the cortical hand area” now started to respond to stimuli applied to the lower 
face region. Since this patch of cortex is more than 1 cm wide, they concluded that sensory 
reorganisation could occur over at least this distance, i.e. an order of magnitude ten times 
greater than the original 1 mm limit. 
In addition to these long-term changes that are typically seen weeks or months after 
deprivation or stimulation, Calford and Tweelade (Calford, 1990) reported rapid, short term 
changes that are based, presumably, on the unmasking of pre-existing connections rather 
than on anatomical “sprouting”. They anaesthetized the middle finger of flying foxes and 
found that within 20 minutes the cortical neurons in the primary somatosensory cortex that 
originally responded to the middle finger could then be activated by touching the adjacent 
digits, indicating that the receptive fields had expanded to include adjacent digits. 
Calford and Tweedale (Calford, 1990) also showed that a small unilateral peripheral 
denervation in adult flying foxes lead to expansion of the cortical receptive field for 
neighboring skin areas as predicted from the work of Merzenich et al (Merzenich et al., 
1984). 
Rapid plasticity changes are typically seen minutes after injury or an intervention, and are 
often based on decreased inhibition.  Decreased inhibition would theoretically increase the 
receptive field size and enable more neurons to be activated by the stimulus. This is 
sometimes referred to as unmasking of synapses or neural structures.   
 Surprisingly, the receptive field of the homotopic region in the other hemisphere mirrored 
the change. In other words, the second hemisphere learned what the first had done; it 
copied the revised sensory map. Maintaining symmetric sensory representation of the two 
sides in the cerebral cortex may be important for the control of symmetric bilateral motor 
activity. 
Experience dependent plasticity refers to the ability of the adult brain to adjust itself to 
changes in environmental conditions. It relates to the learning of special skills that requires 
special training and it often requires motivation and concentration on the task.  
Another example of brain plasticity is the so called cross-modal plasticity. This phenomenon 
implies that one sensory modality can substitute for another (Bavelier & Neville, 2002). The 
most well known example is in blind persons where an improved sensory function is 
noticed. It has also been shown that when a blind person reads Braille activation in the 
occipital lobe occurs implying that the somatosensory stimuli from reading activates the 
cortical area responsible for vision (Gizewski et al., 2003). 
Another example is persons in whom the lack of sensibility can be substituted with hearing. 
Through small microphones on the fingers the persons can, after a short training period, 
listen to what they feel (Lundborg et al., 1999). A crucial element in such cross-modal 
plasticity seems to be training, in order for a sensory modality to “take over” another 
sensory modality. 
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3.2 Mechanisms of plasticity 
Several cellular mechanisms by which the adult brain can adjust to changes in the 
environment or in sensory input have been defined, including the following (Kandel et al., 
2000; Purves, 2004). 
Decreased inhibition 
Many connections between the periphery and the cortex as well as intracortical connections 
are physiologically “silent” because of inhibitory influences (Wall, 1977). Sensory 
stimulation of a point on the skin activates neurons in the somatosensory system near the 
centre of the area of cortical representation and inhibits activity in neurons near the edges. 
In this way the receptive field appears smaller than its actual size. The inhibition is due to 
activation of inhibitory interneurons near the edges of the receptive field. Decreased 
inhibition would theoretically increase the receptive field size and enable more neurons to 
be activated by the stimulus; this is sometimes referred to as unmasking of synapses or 
neural structures. Gamma-aminobutyric acid (GABA) is the most important inhibitory 
neurotransmittor in the brain (Jones, 1993) and evidence is strong that reduction of 
GABAergic inhibition is crucial in mediating short term plasticity changes (Chen et al., 
2002). 
Increase in synaptic strength 
The effectiveness of synaptic connections is continuously adopted in response to functional 
demands. Synaptic transmission becomes facilitated in a pathway that is frequently used, 
while those that lay dormant atrophy. In this way, repeated practice of a task leads to 
increased speed and accuracy of performance. Increased synaptic strength may be a 
mechanism for learning and also for recovery from brain injury. Repetitive stimulation 
results in increased excitability and facilitation of transmission in the synapses. These effects 
persist for some time after the initial stimulus and subsequently show gradual declines (long 
term potentiation, LTP). Calcium channels in the neuronal membrane appear to be crucial in 
this process. LTP is probably one of the major mechanism by which learning and memory 
consolidation takes place in the brain (Kandel et al., 2000). 
Axonal and dendritic sprouting 
The sprouting and elongation of new dendrites and axons is a common response to injury and 
cell loss at all levels in the nervous system. Sprouting can also be seen in response to increased 
functional demand, such as exposure to conditions requiring more complex motor activity 
(Kleim et al., 1996). Axons at the edges of a lesion send new axonal branches into the damaged 
area and re-innervate dendrites that have lost their synaptic input. This leads to new synaptic 
formation at the point of contact of axonal sprouts with these dendritic trees. This mechanism 
for recovery has been suggested in, for example, the reaction of the somatosensory cortex to 
loss of its input from the skin (Merzenich et al., 1984; Pons et al., 1991). 
3.3 Targeted plasticity 
The primary somatosensory-and motorcortex is organized somatotopically, where different 
body parts project to different parts of the primary somatosensory-and motor cortex (Figure 
1). The somatotopic map does not represent the body in its actual proportions. Instead, 
larger cortical areas are being assigned to sensitive parts or parts with complex motor 
demands, such as the hands and face. The cortical representation of different body parts 
alters constantly, depending on the pattern of afferent nerve impulses, injury and increased 
or decreased use.  
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Fig. 1. Sensory information is sent from, in this case, the hand via the peripheral nerve to the 
dorsal root ganglia, spinal cord and thalamus to the primary somatosensory cortex. Motor 
information is sent from the primary motor cortex to the spinal cord and the effector 
muscles. 
Both the primary somatosensory and motor cortex are arranged somatotopically. Thus in 
each hemisphere there is a complete somatotopic map of the body both in the primary 
somatosensory and motor cortex.  
To utilize the central nervous systems’ (CNS) ability to change for therapeutic purposes, 
guided plasticity is an attractive concept with promising results (Duffau, 2006). The 
potential for cerebral plasticity is, for example, used in treatment of patients to strengthen or 
promote CNS functions that are lost or weakened. The plastic potential of the brain might be 
guided using neurosurgical methods, rehabilitation and different pharmacological drugs in 
order to improve lost or damaged functions (Duffau, 2006). The use of neurosurgical 
methods is very complicated, sometimes including complex surgical interventions, which 
limit the usefulness. The use of potent drugs affecting the central nervous system, such as 
amphetamine (Walker-Batson et al., 2001) and norepinephrine (Plewnia et al., 2004), in order 
to improve recovery of damaged function, have been described. However, few patients 
currently benefit from such treatments due to incomplete knowledge of optimal treatment 
regimes and side effects from the drugs.   
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Our main objective when starting to develop a treatment regime for diabetic neuropathy 
was to look for a method more suitable for patient usage, giving a cortical deafferentation 
“large” enough to induce changes in peripheral function but not unnecessarily large. The 
method should also be safe with no side effects, pain free, and easy to us for both patient 
and therapist. Furthermore, it should be specific for sensory functions not affecting the 
motor function as this would affect the person’s ability to perform motor tasks. 
 It is well known from animal and human experiments that temporary cutaneous anesthesia 
of one body part leads to cortical re-organization resulting in a corresponding silent area in 
the sensory cortex. This allows adjacent nearby body parts to rapidly expand at the expense 
of the silent cortical area this is likely mediated by unmasking of existing synapses. 
  The forearm is located next to the hand in the somatotopic map and by anaesthetizing the 
forearm, the cortical hand area can rapidly expand over the forearm area resulted in 
improved sensory function of the hand in healthy controls (Bjorkman et al., 2009). Thus, 
more nerve cells can be available for the hand, resulting in improved hand function. In a 
randomized, controlled trial, sensory re-learning in combination with cutaneous forearm 
anesthesia, using an anesthetic cream, EMLA® containing 2.5% lidocain and 2.5% prilokain, 
improved sensory function of the hand compared with sensory re-learning and placebo in 
patients with ulnar or median nerve repair (Rosen et al., 2006). The participants received 
treatment twice a week for two consecutive weeks, and the effects lasted 4 weeks after the 
last EMLA® treatment. These results suggest that sensory recovery is enhanced by 
temporary anesthesia of adjacent body parts. The long lasting effect indicates that this 
treatment is clinically useful and relevant.  
Recently, the same principle of temporary cutaneous anesthesia as that used for the hand 
has been applied on the foot in uninjured subjects. In a randomized controlled trial, 
improvement in sensory function of the foot was observed after EMLA® treatment of the 
lower leg compared to placebo (Rosen et al., 2009). 
There is no specific treatment for neuropathy in diabetes except a strict control of the 
glycaemic level. However, recent data in healthy subjects and diabetic patients show that 
the sensory function in the foot and hand, measured by the monofilament test, can be 
improved by using the central nervous systems ability to change, i.e. brain plasticity. In a 
recent double blind randomized placebo controlled study male (n=26) or female (n=5) 
diabetic patients with type 1 (n=30) or type 2 (n=7) with a median duration of diabetes of 35 
years, all with insulin treated diabetes, were either treated with EMLA® cream or placebo 
cream applied to the skin of the lower leg for 1.5 hours (n=18 and n=19, respectively). All 
the subjects in the EMLA® group with pre-treatment diminished protective sensibility at the 
first metatarsal head showed improved touch threshold below limits for protective 
sensibility after 1.5 and 24 hours, while no such changes were observed after the treatment 
with placebo cream (Fig 2).    
Furthermore, the touch thresholds improved at four other assessment sites (third metatarsal 
head, fifth metatarsal head, pulp of big toe and central of heal) together with increased 
vibration threshold at 125 Hz. However, the patients observed no subjective improvement, 
based on examination with a visual analogue scale, after treatment. This new strategy to 
improve the thresholds of touch creates new possibilities to treat disturbances in sensation 
of the diabetic foot. Hypothetically, the local anaesthetic cream results in a deafferentation of 
the lower leg in the primary somatosensory cortex, which allows the foot to expand. Thus, 
more nerve cells are available for the foot resulting in the observed improved sensory 
function.  
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A challenge is to create a long lasting improvement of the sensory function.  Studies using 
cutaneous anaesthesia in the upper extremity in patients with nerve injuries and neuropathy 
have shown that a lasing improvement of sensibility is possible using repeated sessions with 
cutaneous anaesthesia (Rosen et al., 2008; Rosen et al., 2006). 
In conclusion, treatment of diabetic neuropathy is complicated. However, new knowledge 
on the effect of a peripheral nerve injury and neuropathy on the central nervous system 
opens new perspectives to treat neuropathy by targeted plasticity. Cutaneous anaesthesia of 
the lower leg in diabetic patients is a good example of how targeted plasticity is used in 
order to improve foot sensibility in patients with diabetic neuropathy. The method is 
simple, safe, and cost-effective, although future studies are needed to work out the optimal 
treatment regime for a long lasting or permanent improvement in sensibility. 
 
 
Fig. 2. Change of touch threshold in first  metatarsal head in diabetic patients between pre-
treatment and after 1.5 h of EMLA® treatment compared with placebo (P < 0.001). 
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